TransMedics Group (STU:TMDX) Cash-to-Debt : 0.68 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is TransMedics Group Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. TransMedics Group's cash to debt ratio for the quarter that ended in Mar. 2024 was 0.68.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, TransMedics Group couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for TransMedics Group's Cash-to-Debt or its related term are showing as below:

STU:TMDX' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.36 Med: 2.59 Max: 4.05
Current: 0.68

During the past 8 years, TransMedics Group's highest Cash to Debt Ratio was 4.05. The lowest was 0.36. And the median was 2.59.

STU:TMDX's Cash-to-Debt is ranked worse than
68.21% of 862 companies
in the Medical Devices & Instruments industry
Industry Median: 1.935 vs STU:TMDX: 0.68

TransMedics Group Cash-to-Debt Historical Data

The historical data trend for TransMedics Group's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

TransMedics Group Cash-to-Debt Chart

TransMedics Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

2.36

3.63

2.11

2.98

0.77

TransMedics Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															2.90	1.13	0.83	0.77	0.68

Competitive Comparison of TransMedics Group's Cash-to-Debt

For the Medical Devices subindustry, TransMedics Group's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TransMedics Group's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where TransMedics Group's Cash-to-Debt falls into.

TransMedics Group Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

TransMedics Group's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	362.043	/	(1.866	+	471.256)
	=	0.77

TransMedics Group's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	322.2	/	(1.919	+	473.006)
	=	0.68

TransMedics Group (STU:TMDX) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

TransMedics Group Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of TransMedics Group's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

TransMedics Group (STU:TMDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » TransMedics Group Inc (STU:TMDX) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

TMDX:USA 8T8:Germany

Address

200 Minuteman Road, Andover, MA, USA, 01810

Website

https://www.transmedics.com

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body.